Our Members

Alcanza Clinical Research

Founded in 2021, Alcanza Clinical Research’s platform conducts clinical trials across phases I-IV in various therapeutic areas, including vaccines, neurology, psychiatry, metabolic and dermatology. Alcanza focuses on promoting inclusivity within its staff and diverse patient populations from communities surrounding its sites to provide high-quality research opportunities. With a network of locations across the U.S. including Puerto Rico, Alcanza is dedicated to reducing barriers to clinical trial participation while maintaining a strong emphasis on patient care and data integrity.

Alliance for Multispecialty Research (AMR)

Founded in 1994, AMR is a leading clinical research organization consisting of fully-owned and affiliate research centers across the U.S. With 32 locations, AMR has conducted more than 7,700 clinical trials and enrolled over 145,000 participants. Specializing in Phase I-IV clinical trials, AMR offers expertise in various therapeutic areas such as cardiology, dermatology, endocrinology, vaccines, and more. AMR’s success is built on strong relationships with sponsors, CROs, and healthcare providers, delivering high-quality data and consistent patient recruitment to accelerate drug development​.

CenExel

CenExel is a leading, nationwide clinical research site network dedicated to advancing global human health through exceptional medical research. With over 40 years of experience, its Centers of Excellence provide unparalleled scientific expertise, operational efficiency, and patient engagement across a wide array of therapeutic areas. It is committed to delivering the right patients, at the right time, to the right clinical site investigators, ensuring the development of better, safer therapies.

Centricity Research

Centricity Research is one of the largest fully centralized Integrated Research Organizations (IROs) in North America, with over 40 sites across the U.S. and Canada. It specializes in conducting Phase I-IV clinical trials across more than 35 therapeutic areas, including infectious diseases, oncology, cardiology, and vaccines. With a network that includes 150 active investigators and access to over 7.8 million patients, Centricity aims to revolutionize clinical research by making it more accessible and efficient for patients, providers, sponsors, and CROs​.

DM Clinical Research

DM Clinical Research is a tech-forward leader in clinical trials, integrating diversity and centralized management to advance medical innovation. With a robust network of over 24 sites across the US, DM Clinical delivers high-quality, patient-centric research across diverse therapeutic areas like Infectious Disease and vaccines, Cardio-metabolic, CNS and Immunology. Their approach emphasizes cutting-edge technology and data integration, making them a trusted partner for pharmaceutical and biotechnology companies seeking reliable clinical data. DM Clinical aims to accelerate drug development through inclusivity, operational excellence, and innovation.

Evolution Research Group (ERG)

Evolution Research Group (ERG) is a leading independent clinical research site network, specializing in both inpatient and outpatient Phase I-IV clinical trials. ERG is highly regarded for its work in central nervous system (CNS) studies and other therapeutic areas such as psychiatry, neurology, sleep disorders, addiction, and diabetes. With a robust network of wholly owned and affiliated sites, ERG supports clinical trials through centralized operations that streamline recruitment, regulatory planning, and quality assurance. Their comprehensive services help sponsors accelerate the development of life-enhancing therapies.

Flourish Research

Flourish Research is a multi-site clinical trial company with a national footprint, specializing in cardiovascular/metabolic, neuroscience, and infectious diseases. By integrating best-in-class sites across various locations, Flourish accelerates the development of innovative treatments and provides a single point of entry for sponsors and CROs. Their sites are known for rapid recruitment, patient retention, and diversity, making them leaders in conducting high-quality clinical trials across the U.S. Their mission is to enhance patient health and wellness through clinical research​.

Headlands Research

Headlands Research is a multinational clinical trial site organization with a mission to improve lives by advancing innovative medical therapies. They focus on large-volume recruitment and retention of diverse, inclusive patient populations through extensive site databases and physician partnerships. With over 5,000 clinical trials successfully completed and key expertise across a broad range of therapeutic areas, Headlands Research strives to ensure operational excellence and high-quality data. Their commitment to diversity and inclusion helps drive clinical trials that reflect real-world populations, supporting a wide range of medical advancements​.

Helios Clinical Research

Helios Clinical Research is an integrated clinical site organization specializing in vaccines, metabolic, urology, orthopedics, gastroenterology, dermatology, oncology, and broader general medicine. With over 20 clinical sites across the U.S., Helios partners with patients, physicians, and biopharma sponsors to streamline the clinical research process. Their focus is on accelerating the availability of important new therapies by optimizing patient recruitment, regulatory compliance, and quality management in clinical trials.

IMA Clinical Research

IMA Clinical Research is a network of clinical research sites with access to 150 satellite clinics which provides extensive, nationwide patient reach. With experienced investigators and clinicians, the network specializes in Phase II-IV, post-approval, site-based, hybrid, and fully decentralized trials across various therapeutic areas, including CNS, metabolic, vaccines, and more. IMA ensures efficient trial execution with centralized services for rapid startup—offering one budget, one contract, and streamlined regulatory submissions. The network emphasizes patient diversity, high retention, and quality care to advance the development of new medical treatments.

Javara

Javara, a leading Integrated Research Organization (IRO), partners with large healthcare systems to bring clinical research closer to home. With embedded teams and infrastructure, Javara is making clinical trials accessible at the point of care, reaching patients through their trusted physician. Centralized resources and standardized operations provide efficiencies for accelerated study start-up, representative results and quality outcomes, so fewer obstacles stand in the way of the product approval process. Pioneers of Clinical Research as a Care Option (CRAACO), Javara is transforming healthcare through the power of predictability.

Paradigm Clinical Research

Founded in 2009, Paradigm Clinical Research operates a growing roster of wholly owned research sites providing access to diverse and under-represented populations and investigators. We partner with investigators in a variety of specialties on both healthy volunteer and patient studies. We are uniquely positioned to deliver superior value by continuously lowering barriers to study participation. Our mission is to enrich the lives of those we serve by offering opportunities to advance the human condition through participation in brilliantly executed clinical trials.

Tekton Research

Tekton Research operates a network of clinical research sites across the U.S. specializing in a broad range of clinical trials for pharmaceutical and device companies. Their focus areas include vaccines, infectious diseases, neurology, endocrinology, and dermatology, among others. Tekton is committed to enhancing access to clinical research for diverse populations while helping bring new treatments to market.

Velocity Clinical Research

Velocity Clinical Research is a globally recognized leader in the clinical trial site industry, specializing in fully integrated research sites. Headquartered in Durham, NC, Velocity partners with pharmaceutical and biotechnology companies to conduct clinical trials across the U.S. and Europe. With over 90 research sites and more than one million participants, they have supported the development of new drugs, medical devices, and diagnostics through Phase I-IV clinical trials. Velocity’s approach focuses on ensuring patient-centric care while accelerating drug development through superior patient recruitment and reliable data collection​.